Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-05-19

FDA Approved: DIVALPROEX SODIUM — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

FDA supplemental application for divalproex sodium filed by NorthStar Rx LLC, likely involving labeling updates or other product changes. The action pertains to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIVALPROEX SODIUM (divalproex sodium)

Snippet

SUPPL AP for DIVALPROEX SODIUM (DIVALPROEX SODIUM)